CY1105664T1 - Ομοιογενως επικαλυμμενη διαταξη εχουσα οστεοεπαγωγικες και οστεοαγωγους ιδιοτητες - Google Patents
Ομοιογενως επικαλυμμενη διαταξη εχουσα οστεοεπαγωγικες και οστεοαγωγους ιδιοτητεςInfo
- Publication number
- CY1105664T1 CY1105664T1 CY20051101348T CY051101348T CY1105664T1 CY 1105664 T1 CY1105664 T1 CY 1105664T1 CY 20051101348 T CY20051101348 T CY 20051101348T CY 051101348 T CY051101348 T CY 051101348T CY 1105664 T1 CY1105664 T1 CY 1105664T1
- Authority
- CY
- Cyprus
- Prior art keywords
- osteoconductive properties
- osteoinductive
- treatment
- osteopulative
- homogeneously coated
- Prior art date
Links
- 230000000278 osteoconductive effect Effects 0.000 title abstract 3
- 210000000988 bone and bone Anatomy 0.000 abstract 3
- 230000002138 osteoinductive effect Effects 0.000 abstract 3
- 238000001727 in vivo Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000003416 augmentation Effects 0.000 abstract 1
- 229910000389 calcium phosphate Inorganic materials 0.000 abstract 1
- 239000001506 calcium phosphate Substances 0.000 abstract 1
- 235000011010 calcium phosphates Nutrition 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Apparatuses And Processes For Manufacturing Resistors (AREA)
- Permanent Magnet Type Synchronous Machine (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Dental Preparations (AREA)
- Prostheses (AREA)
- Peptides Or Proteins (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μία διάταξη έχουσα οστεοεπαγωγικές και οστεοαγωγούς ιδιότητες in vivo περιλαμβάνουσα ένα φορέα περιέχοντα φωσφορικό ασβέστιο και μία οστεοεπαγωγική πρωτεΐνη, όπου ο εν λόγω φορέας είναι ομοιογενώς επικαλυμμένος με την εν λόγω πρωτεΐνη. Επί πλέον, η παρούσα εφεύρεση αναφέρεται σε μία μέθοδο για την παραγωγή μίας διατάξεως εχούσης οστεοεπαγωγικές και οστεοαγωγούς ιδιότητες in vivo. Η εφεύρεση περιλαμβάνει μία φαρμακευτική σύνθεση περιέχουσα τη διάταξη της εφευρέσεως ή μία διάταξη η οποία μπορεί να ληφθεί δια της μεθόδου της εφευρέσεως και αναφέρεται στη χρήση της εν λόγω διατάξεως για την παρασκευή μίας φαρμακευτικής συνθέσεως προς χρήση για την επαύξηση των οστών, για την αγωγή βλαβών των οστών, για την αγωγή της εκφυλιστικής και της τραυματικής δισκοπάθειας, για την αγωγή της διαρρήξεως των οστών ή προς χρήση για την ανύψωση του δαπέδου της κοιλότητος. Τέλος, η εφεύρεση αναφέρεται σε ένα σετ περιλαμβάνον τη διάταξη της εφευρέσεως ή μία διάταξη η οποία μπορεί να ληφθεί δια της μεθόδου της εφευρέσεως.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01127573 | 2001-11-19 | ||
PCT/EP2002/003463 WO2003043673A1 (en) | 2001-11-19 | 2002-03-27 | Device having osteoinductive and osteoconductive properties |
EP02803343.9A EP1448246B2 (en) | 2001-11-19 | 2002-03-27 | Method for producing a homogeneously coated device having osteoinductive and osteoconductive properties |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105664T1 true CY1105664T1 (el) | 2010-12-22 |
Family
ID=8179288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20051101348T CY1105664T1 (el) | 2001-11-19 | 2005-11-04 | Ομοιογενως επικαλυμμενη διαταξη εχουσα οστεοεπαγωγικες και οστεοαγωγους ιδιοτητες |
Country Status (16)
Country | Link |
---|---|
US (2) | US8546334B2 (el) |
EP (1) | EP1448246B2 (el) |
JP (2) | JP4473576B2 (el) |
CN (1) | CN100425285C (el) |
AT (1) | ATE303169T1 (el) |
AU (1) | AU2002308204B9 (el) |
BR (1) | BR0214275A (el) |
CA (1) | CA2466947C (el) |
CY (1) | CY1105664T1 (el) |
DE (1) | DE60205937T3 (el) |
DK (1) | DK1448246T4 (el) |
ES (1) | ES2247423T5 (el) |
HK (1) | HK1071315A1 (el) |
PT (1) | PT1448246E (el) |
SI (1) | SI1448246T2 (el) |
WO (1) | WO2003043673A1 (el) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1462126A1 (en) * | 2003-03-28 | 2004-09-29 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Improved Osteoinductive Materials |
DE602005022998D1 (de) | 2004-03-10 | 2010-09-30 | Scil Technology Gmbh | Überzogene implantate, ihre herstellung und verwendung davon |
EP1604693A1 (en) | 2004-06-09 | 2005-12-14 | Scil Technology GmbH | In situ forming scaffold, its manufacturing and use |
EP1604694A1 (en) * | 2004-06-09 | 2005-12-14 | Scil Technology GmbH | Composite device having osteoinductive and osteoconductive properties |
US20100112028A1 (en) * | 2004-06-09 | 2010-05-06 | Klaus Hellerbrand | Composite material for use as protein carrier |
US20060286171A1 (en) * | 2005-06-17 | 2006-12-21 | Tianhong Zhou | Bone morphogenetic protein formulations |
AU2006326271B2 (en) * | 2005-12-14 | 2011-02-24 | Scil Technology Gmbh | A moldable biomaterial for bone regeneration |
US20070299520A1 (en) * | 2006-06-26 | 2007-12-27 | Warsaw Orthopedic, Inc. | Surface treatment of implantable devices |
AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
DE102006060958A1 (de) * | 2006-12-20 | 2008-06-26 | Jennissen, Herbert P., Prof. Dr. | Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung |
US20080221681A1 (en) * | 2007-03-09 | 2008-09-11 | Warsaw Orthopedic, Inc. | Methods for Improving Fatigue Performance of Implants With Osteointegrating Coatings |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
CA2695697A1 (en) | 2007-08-07 | 2009-02-12 | Advanced Technologies And Regenerative Medicine, Llc | Protein formulations comprising gdf-5 in aqueous acidic solution |
US20090061002A1 (en) * | 2007-09-05 | 2009-03-05 | Venbrocks Rudolf A | Calcium phospate based delivery of growth and differentiation factors to compromised bone |
DE102007051914A1 (de) * | 2007-10-29 | 2009-05-07 | Herbert Prof. Dr. Jennissen | Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel |
EP2276458A1 (en) | 2008-04-14 | 2011-01-26 | Advanced Technologies and Regenerative Medicine, LLC | Liquid buffered gdf-5 formulations |
US20110059149A1 (en) * | 2008-06-16 | 2011-03-10 | Little Marisa A | Process for depositing calcium phosphate therapeutic coatings with different release rates and a prosthesis coated via the process |
ES2818373T3 (es) | 2009-05-28 | 2021-04-12 | Addbio Ab | Películas de proteína de múltiples capas, métodos de preparación y dispositivos de suministro de fármacos e implantes biomédicos que emplean las películas |
CA2806143A1 (en) * | 2010-07-30 | 2012-02-02 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mb H | Drug delivery devices and growth factor formulations for accelerated wound healing |
WO2012093939A1 (en) | 2011-01-05 | 2012-07-12 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg | Particles comprising calcium phosphate and use thereof |
EP3682931A1 (en) * | 2019-01-21 | 2020-07-22 | Universitätsklinikum Hamburg-Eppendorf | Thoracic catheter |
Family Cites Families (139)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3329128A1 (de) | 1983-08-11 | 1985-02-28 | Bayer Ag, 5090 Leverkusen | 3-cycloalkyl-1-(1,3-dioxan-5-yl)-2-(1,2,4-triazol-1-yl)-propan-1-one und -propan-1-ole |
US4596574A (en) * | 1984-05-14 | 1986-06-24 | The Regents Of The University Of California | Biodegradable porous ceramic delivery system for bone morphogenetic protein |
US5543394A (en) | 1986-07-01 | 1996-08-06 | Genetics Institute, Inc. | Bone morphogenetic protein 5(BMP-5) compositions |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
ZA874681B (en) | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
US6432919B1 (en) | 1986-07-01 | 2002-08-13 | Genetics Institute, Inc. | Bone morphogenetic protein-3 and compositions |
US5366875A (en) | 1986-07-01 | 1994-11-22 | Genetics Institute, Inc. | Methods for producing BMP-7 proteins |
US5106748A (en) | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
US6150328A (en) | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
IL83003A (en) | 1986-07-01 | 1995-07-31 | Genetics Inst | Factors that soak bone formation |
US4877864A (en) | 1987-03-26 | 1989-10-31 | Genetics Institute, Inc. | Osteoinductive factors |
US5187076A (en) | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
US5939388A (en) | 1986-07-01 | 1999-08-17 | Rosen; Vicki A. | Methods of administering BMP-5 compositions |
US5459047A (en) | 1986-07-01 | 1995-10-17 | Genetics Institute, Inc. | BMP-6 proteins |
US5631142A (en) | 1986-07-01 | 1997-05-20 | Genetics Institute, Inc. | Compositions comprising bone morphogenetic protein-2 (BMP-2) |
WO1990011366A1 (en) | 1989-03-28 | 1990-10-04 | Genetics Institute, Inc. | Osteoinductive compositions |
US5108922A (en) | 1986-07-01 | 1992-04-28 | Genetics Institute, Inc. | DNA sequences encoding BMP-1 products |
US5670336A (en) | 1988-04-08 | 1997-09-23 | Stryker Corporation | Method for recombinant production of osteogenic protein |
US4975526A (en) | 1989-02-23 | 1990-12-04 | Creative Biomolecules, Inc. | Bone collagen matrix for zenogenic implants |
US5162114A (en) | 1989-02-23 | 1992-11-10 | Stryker Corporation | Bone collagen matrix for xenogenic implants |
US5344654A (en) | 1988-04-08 | 1994-09-06 | Stryker Corporation | Prosthetic devices having enhanced osteogenic properties |
US5258494A (en) | 1988-04-08 | 1993-11-02 | Stryker Corporation | Osteogenic proteins |
US6586388B2 (en) | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
JP2522568B2 (ja) | 1988-04-08 | 1996-08-07 | ストライカー・コーポレーション | 骨形成デバイス |
US5266683A (en) | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
US5011691A (en) | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
US5354557A (en) | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
US5324819A (en) | 1988-04-08 | 1994-06-28 | Stryker Corporation | Osteogenic proteins |
US5258029A (en) | 1988-09-29 | 1993-11-02 | Collagen Corporation | Method for improving implant fixation |
US5207710A (en) † | 1988-09-29 | 1993-05-04 | Collagen Corporation | Method for improving implant fixation |
US5108436A (en) | 1988-09-29 | 1992-04-28 | Collagen Corporation | Implant fixation |
US5158934A (en) | 1989-09-01 | 1992-10-27 | Genentech, Inc. | Method of inducing bone growth using TGF-β |
US5422340A (en) | 1989-09-01 | 1995-06-06 | Ammann; Arthur J. | TGF-βformulation for inducing bone growth |
JP2845346B2 (ja) | 1989-10-17 | 1999-01-13 | ストライカー・コーポレーション | 骨形成具 |
DK27390D0 (da) | 1990-02-02 | 1990-02-02 | Troels Torp Andreassen | Fremgangsmaade og apparat til administration af biologisk aktive stoffer |
ATE168719T1 (de) | 1990-10-18 | 1998-08-15 | Stryker Corp | Osteogene peptide |
US5652118A (en) | 1991-03-11 | 1997-07-29 | Creative Biomolecules, Inc. | Nucleic acid encoding a novel morphogenic protein, OP-3 |
CA2363965C (en) | 1991-03-11 | 2010-05-18 | Curis, Inc. | Protein-induced morphogenesis |
US5674844A (en) | 1991-03-11 | 1997-10-07 | Creative Biomolecules, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
US5972884A (en) | 1991-03-11 | 1999-10-26 | Creative Biomolecules, Inc. | Morphogen treatment of gastrointestinal ulcers |
US5652337A (en) | 1991-03-11 | 1997-07-29 | Creative Biomolecules, Inc. | OP-3-induced morphogenesis |
US6723698B2 (en) | 1991-03-11 | 2004-04-20 | Curis, Inc. | Methods and compositions for the treatment of motor neuron injury and neuropathy |
US5707810A (en) | 1991-03-11 | 1998-01-13 | Creative Biomolecules, Inc. | Method of diagnosing renal tissue damage or disease |
US6211146B1 (en) | 1991-03-11 | 2001-04-03 | Curis, Inc. | 60A protein-induced morphogenesis |
US6495513B1 (en) | 1991-03-11 | 2002-12-17 | Curis, Inc. | Morphogen-enhanced survival and repair of neural cells |
US6077823A (en) | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
US6395883B1 (en) | 1991-03-11 | 2002-05-28 | Curis, Inc. | Soluble morphogenic protein complex compositions of matter |
US6800603B2 (en) | 1991-03-11 | 2004-10-05 | Curis, Inc. | Morphogen-induced neural cell adhesion |
US6194376B1 (en) | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
US6506729B1 (en) | 1991-03-11 | 2003-01-14 | Curis, Inc. | Methods and compositions for the treatment and prevention of Parkinson's disease |
DE69231946T2 (de) | 1991-03-11 | 2002-04-04 | Curis Inc | Protein-induzierende morphogenese |
US5650276A (en) | 1991-03-11 | 1997-07-22 | Creative Biomolecules, Inc. | Morphogenic protein screening method |
US5849686A (en) | 1991-03-11 | 1998-12-15 | Creative Biomolecules, Inc. | Morphogen-induced liver regeneration |
US6090776A (en) | 1991-03-11 | 2000-07-18 | Creative Bio Molecules, Inc. | Morphogen treatment of organ implants |
US5656593A (en) | 1991-03-11 | 1997-08-12 | Creative Biomolecules, Inc. | Morphogen induced periodontal tissue regeneration |
US6399569B1 (en) | 1991-03-11 | 2002-06-04 | Curis, Inc. | Morphogen treatments for limiting proliferation of epithelial cells |
US5290763A (en) | 1991-04-22 | 1994-03-01 | Intermedics Orthopedics/Denver, Inc. | Osteoinductive protein mixtures and purification processes |
US5563124A (en) | 1991-04-22 | 1996-10-08 | Intermedics Orthopedics/ Denver, Inc. | Osteogenic product and process |
US5177406A (en) | 1991-04-29 | 1993-01-05 | General Motors Corporation | Active matrix vacuum fluorescent display with compensation for variable phosphor efficiency |
DE4121043A1 (de) | 1991-06-26 | 1993-01-07 | Merck Patent Gmbh | Knochenersatzmaterial mit fgf |
EP0523926A3 (en) | 1991-07-15 | 1993-12-01 | Smith & Nephew Richards Inc | Prosthetic implants with bioabsorbable coating |
US6022853A (en) | 1991-08-30 | 2000-02-08 | Creative Biomolecules, Inc. | Morphogen-enriched dietary composition |
WO1993005751A2 (en) | 1991-08-30 | 1993-04-01 | Creative Biomolecules, Inc. | Osteogenic proteins in the treatment of bone deseases |
DE69231062T3 (de) | 1991-08-30 | 2004-07-29 | Creative Biomolecules, Inc., Hopkinton | Morphogen-induzierte Modulation von entzündlichen Antworten |
SE469653B (sv) | 1992-01-13 | 1993-08-16 | Lucocer Ab | Poroest implantat |
KR0172186B1 (ko) | 1992-02-12 | 1999-02-01 | 미하엘 파울리스타 | 신규의 성장/분화인자를 암호화하는 dna 서열 |
US6120760A (en) | 1992-02-12 | 2000-09-19 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung | Growth/differentiation factors of the TGF-β family |
US5876452A (en) | 1992-02-14 | 1999-03-02 | Board Of Regents, University Of Texas System | Biodegradable implant |
US6013853A (en) | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
WO1993015694A1 (en) | 1992-02-14 | 1993-08-19 | Board Of Regents, The University Of Texas System | Multi-phase bioerodible implant/carrier and method of manufacturing and using same |
US5610021A (en) | 1992-02-21 | 1997-03-11 | Creative Biomolecules, Inc. | Compositions and methods for identification and use of soluble complex forms of osteogenic proteins |
US6071695A (en) | 1992-02-21 | 2000-06-06 | Creative Biomolecules, Inc. | Methods and products for identification of modulators of osteogenic protein-1 gene expression |
US5397235A (en) | 1993-07-02 | 1995-03-14 | Dental Marketing Specialists, Inc. | Method for installation of dental implant |
EP1439190A1 (en) | 1993-01-12 | 2004-07-21 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-5 |
AU671721B2 (en) | 1993-01-12 | 1996-09-05 | Genentech Inc. | Tgf-beta formulation for inducing bone growth |
US5385887A (en) * | 1993-09-10 | 1995-01-31 | Genetics Institute, Inc. | Formulations for delivery of osteogenic proteins |
AU689184B2 (en) | 1993-12-07 | 1998-03-26 | Genetics Institute, Llc | BMP-12, BMP-13 and tendon-inducing compositions thereof |
US6027919A (en) | 1993-12-07 | 2000-02-22 | Genetics Institute, Inc. | BMP-12 and BMP-13 proteins and DNA encoding them |
US6013517A (en) | 1994-05-09 | 2000-01-11 | Chiron Corporation | Crossless retroviral vectors |
US5681746A (en) | 1994-12-30 | 1997-10-28 | Chiron Viagene, Inc. | Retroviral delivery of full length factor VIII |
CA2214341A1 (en) | 1995-03-01 | 1996-09-06 | Creative Biomolecules, Inc. | Morphogen-induced dentine regeneration |
US5782919A (en) * | 1995-03-27 | 1998-07-21 | Sdgi Holdings, Inc. | Interbody fusion device and method for restoration of normal spinal anatomy |
US5635372A (en) | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
US6287341B1 (en) | 1995-05-19 | 2001-09-11 | Etex Corporation | Orthopedic and dental ceramic implants |
US6132463A (en) | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
US8333996B2 (en) | 1995-05-19 | 2012-12-18 | Etex Corporation | Calcium phosphate delivery vehicle and adjuvant |
US6117456A (en) | 1995-05-19 | 2000-09-12 | Etex Corporation | Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
US6027742A (en) | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
US6541037B1 (en) | 1995-05-19 | 2003-04-01 | Etex Corporation | Delivery vehicle |
US5676976A (en) | 1995-05-19 | 1997-10-14 | Etex Corporation | Synthesis of reactive amorphous calcium phosphates |
ES2203701T3 (es) | 1995-06-05 | 2004-04-16 | Genetics Institute, Llc | Uso de proteinas morfogenicas de hueso para sanar y reparar uniones de tejido conjuntivo. |
DE69633197T2 (de) * | 1996-02-29 | 2005-08-18 | Bioactive Bone Substitute Oy, Ab | Osteogene vorrichtungen und methode zur herstellung derselben |
DE69716505T2 (de) | 1996-05-10 | 2003-06-26 | Isotis Nv | Implantatwerkstoff und Verfahren zu seiner Herstellung |
EP0806211B1 (en) | 1996-05-10 | 2002-10-23 | IsoTis N.V. | Implant material and process for producing it |
US6143948A (en) | 1996-05-10 | 2000-11-07 | Isotis B.V. | Device for incorporation and release of biologically active agents |
EP0806212B1 (en) † | 1996-05-10 | 2003-04-02 | IsoTis N.V. | Device for incorporation and release of biologically active agents |
US6953594B2 (en) | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
WO1998016268A2 (en) | 1996-10-16 | 1998-04-23 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
DE19647853A1 (de) * | 1996-11-19 | 1998-05-20 | Bioph Biotech Entw Pharm Gmbh | Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität |
US20020082224A1 (en) | 1997-01-14 | 2002-06-27 | Douglas J. Jolly | Non-immunogenic prodrugs and selectable markers for use in gene therapy |
KR100548107B1 (ko) | 1997-01-30 | 2006-02-02 | 바이오팜 게젤샤프트 쭈어 바이오테히놀로지셴 엔트비클룽 폰 파르마카 엠베하 | 뼈 유도 인자 인간 mp52 동결 건조 조성물 |
US6281195B1 (en) | 1997-02-07 | 2001-08-28 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
US20020098222A1 (en) | 1997-03-13 | 2002-07-25 | John F. Wironen | Bone paste |
US20030032586A1 (en) | 1997-05-15 | 2003-02-13 | David C. Rueger | Compositions for morphogen-induced osteogenesis |
WO1999011202A1 (en) | 1997-09-05 | 1999-03-11 | Icet, Inc. | Biomimetic calcium phosphate implant coatings and methods for making the same |
AU747438B2 (en) | 1997-09-24 | 2002-05-16 | Regents Of The University Of California, The | Non-primate lentiviral vectors and packaging systems |
US20020048805A1 (en) | 1998-01-16 | 2002-04-25 | Julie C. Johnston | Feline immunodeficiency virus gene therapy vectors |
WO1999036511A2 (en) | 1998-01-16 | 1999-07-22 | Chiron Corporation | Feline immunodeficiency virus gene therapy vectors |
AU3988799A (en) | 1998-05-13 | 1999-11-29 | Genetix Pharmaceuticals, Inc. | Novel lentiviral packaging cells |
US6261322B1 (en) | 1998-05-14 | 2001-07-17 | Hayes Medical, Inc. | Implant with composite coating |
KR100298178B1 (ko) | 1998-06-29 | 2001-08-07 | 박종섭 | 이미지센서의포토다이오드 |
US6328765B1 (en) | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
US6423544B1 (en) | 1998-12-31 | 2002-07-23 | Chiron Corporation | Compositions and methods for producing recombinant virions |
EP1150726B1 (en) | 1999-02-04 | 2003-11-05 | SDGI Holdings, Inc. | Highly-mineralized osteogenic sponge compositions, and uses thereof |
ES2242600T3 (es) | 1999-02-04 | 2005-11-16 | Sdgi Holdings, Inc. | Composiciones de pasta osteogenica y sus usos. |
US6730297B1 (en) | 1999-05-28 | 2004-05-04 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
SE515695C2 (sv) * | 1999-05-31 | 2001-09-24 | Nobel Biocare Ab | Implantat med beläggning av bentillväxtstimulerande substans för applicering i ben och förfarande vid sådant implantat |
SE514323C2 (sv) | 1999-05-31 | 2001-02-12 | Nobel Biocare Ab | Implantat samt förfarande och användning vid implantat |
SE514202C2 (sv) | 1999-05-31 | 2001-01-22 | Nobel Biocare Ab | På implantat till ben- eller vävnadsstruktur anordnat skikt samt sådant implantat och förfarande för applicering av skiktet |
MXPA02000937A (es) * | 1999-07-28 | 2002-07-30 | Regeneration Tech Inc | Implantes de tejidos con antigenicidad reducida (tar). |
US6696410B1 (en) * | 1999-09-27 | 2004-02-24 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
PT1220693E (pt) | 1999-10-15 | 2005-02-28 | Inst Genetics Llc | Formulacoes para libertacao de proteinas osteogenicas |
DE60012557T2 (de) | 1999-10-15 | 2005-08-04 | Genetics Institute, LLC, Cambridge | Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine |
DE19950386A1 (de) | 1999-10-19 | 2001-05-10 | Miladin Lazarov | Biokompatibler Gegenstand |
AU2001237786A1 (en) † | 2000-02-04 | 2001-08-14 | Chienna B.V. | Proteinaceous coating |
US20020022885A1 (en) * | 2000-05-19 | 2002-02-21 | Takahiro Ochi | Biomaterial |
JP2003534787A (ja) | 2000-05-26 | 2003-11-25 | カイロン コーポレイション | レンチウイルスベクターを使用する神経細胞の形質導入の方法 |
US6533821B1 (en) | 2000-06-22 | 2003-03-18 | Thomas Lally | Bio-adhesive composition, method for adhering objects to bone |
US7419829B2 (en) | 2000-10-06 | 2008-09-02 | Oxford Biomedica (Uk) Limited | Vector system |
WO2002042482A2 (en) | 2000-11-27 | 2002-05-30 | Chiron Corporation | Functional lentiviral vector from an mlv-based backbone |
US20020082679A1 (en) | 2000-12-22 | 2002-06-27 | Avantec Vascular Corporation | Delivery or therapeutic capable agents |
AU2002239655A1 (en) | 2001-01-05 | 2002-07-16 | Duke University | Contrast enhancement agent for magnetic resonance imaging |
US6949251B2 (en) | 2001-03-02 | 2005-09-27 | Stryker Corporation | Porous β-tricalcium phosphate granules for regeneration of bone tissue |
US20030049328A1 (en) | 2001-03-02 | 2003-03-13 | Dalal Paresh S. | Porous beta-tricalcium phosphate granules and methods for producing same |
WO2002083188A2 (en) | 2001-04-16 | 2002-10-24 | Cassidy James J | Dense/porous structures for use as bone substitutes |
WO2002087341A1 (en) | 2001-05-01 | 2002-11-07 | Genetix Pharmaceuticals, Inc. | Novel self-inactivating (sin) lentiviral vectors |
EP1389978B1 (en) | 2001-05-01 | 2009-01-07 | Amedica Corporation | Radiolucent bone graft |
SE519566C2 (sv) | 2001-07-04 | 2003-03-11 | Nobel Biocare Ab | Förfarande för behandling av implantat genom beläggning med kalciumfosfat och bentillväxtstimulerande medel |
SE519564C2 (sv) | 2001-07-04 | 2003-03-11 | Nobel Biocare Ab | Implantat, t ex dentalt implantat, belagt med bentillväxtstimulerande medel |
-
2002
- 2002-03-27 EP EP02803343.9A patent/EP1448246B2/en not_active Expired - Lifetime
- 2002-03-27 JP JP2003545351A patent/JP4473576B2/ja not_active Expired - Fee Related
- 2002-03-27 AU AU2002308204A patent/AU2002308204B9/en not_active Ceased
- 2002-03-27 DE DE60205937.2T patent/DE60205937T3/de not_active Expired - Lifetime
- 2002-03-27 CA CA2466947A patent/CA2466947C/en not_active Expired - Fee Related
- 2002-03-27 SI SI200230206T patent/SI1448246T2/sl unknown
- 2002-03-27 ES ES02803343.9T patent/ES2247423T5/es not_active Expired - Lifetime
- 2002-03-27 BR BR0214275-9A patent/BR0214275A/pt not_active IP Right Cessation
- 2002-03-27 WO PCT/EP2002/003463 patent/WO2003043673A1/en active IP Right Grant
- 2002-03-27 PT PT02803343T patent/PT1448246E/pt unknown
- 2002-03-27 CN CNB028192745A patent/CN100425285C/zh not_active Expired - Fee Related
- 2002-03-27 AT AT02803343T patent/ATE303169T1/de active
- 2002-03-27 US US10/496,399 patent/US8546334B2/en not_active Expired - Fee Related
- 2002-03-27 DK DK02803343.9T patent/DK1448246T4/en active
-
2005
- 2005-05-13 HK HK05104014.9A patent/HK1071315A1/xx not_active IP Right Cessation
- 2005-11-04 CY CY20051101348T patent/CY1105664T1/el unknown
-
2009
- 2009-12-29 JP JP2009299102A patent/JP5054091B2/ja not_active Expired - Fee Related
-
2013
- 2013-09-27 US US14/040,500 patent/US20150080303A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1448246B1 (en) | 2005-08-31 |
BR0214275A (pt) | 2004-09-21 |
AU2002308204B2 (en) | 2007-09-27 |
ES2247423T5 (es) | 2015-12-30 |
EP1448246A1 (en) | 2004-08-25 |
JP2010075737A (ja) | 2010-04-08 |
SI1448246T1 (sl) | 2005-12-31 |
ES2247423T3 (es) | 2006-03-01 |
DE60205937T2 (de) | 2006-06-14 |
HK1071315A1 (en) | 2005-07-15 |
CA2466947A1 (en) | 2003-05-30 |
SI1448246T2 (sl) | 2015-12-31 |
CN1561235A (zh) | 2005-01-05 |
WO2003043673A1 (en) | 2003-05-30 |
JP2005509494A (ja) | 2005-04-14 |
DK1448246T3 (da) | 2005-12-27 |
US20060088565A1 (en) | 2006-04-27 |
CA2466947C (en) | 2012-05-22 |
JP5054091B2 (ja) | 2012-10-24 |
ATE303169T1 (de) | 2005-09-15 |
DK1448246T4 (en) | 2015-12-21 |
DE60205937D1 (de) | 2005-10-06 |
PT1448246E (pt) | 2005-11-30 |
DE60205937T3 (de) | 2016-01-21 |
AU2002308204B9 (en) | 2008-06-12 |
CN100425285C (zh) | 2008-10-15 |
US8546334B2 (en) | 2013-10-01 |
US20150080303A1 (en) | 2015-03-19 |
JP4473576B2 (ja) | 2010-06-02 |
AU2002308204A1 (en) | 2003-06-10 |
EP1448246B2 (en) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105664T1 (el) | Ομοιογενως επικαλυμμενη διαταξη εχουσα οστεοεπαγωγικες και οστεοαγωγους ιδιοτητες | |
Dorozhkin | Calcium orthophosphate bioceramics | |
Rigo et al. | Evaluation in vitro and in vivo of biomimetic hydroxyapatite coated on titanium dental implants | |
HUP0401357A2 (hu) | Kalcium-foszfát hordozóanyagok csontképződést serkentő fehérjék bejuttatásához | |
ES2242916T3 (es) | Metodos de preparacion de segmentos y granulos de fosfato de calcio poroso mediante procesamiento con gelatina. | |
Tamimi et al. | Bone augmentation in rabbit calvariae: comparative study between Bio‐Oss® and a novel β‐TCP/DCPD granulate | |
ES2136668T3 (es) | Fosfato calcico como precursor de la hidroxiapatita y procedimiento para su preparacion y utilizacion. | |
Khairoun et al. | In vitro characterization and in vivo properties of a carbonated apatite bone cement | |
Chou et al. | Controlled release of simvastatin from biomimetic β-TCP drug delivery system | |
NO2014010I1 (no) | Radium 223 salt slik som Radium 223 diklorid | |
BRPI0406694B8 (pt) | polipeptídios terapêutico, seus homólogos, seus fragmentos, que são usados nas modulações da agregação plaquetária | |
Nyangoga et al. | A non-steroidal anti-inflammatory drug (ketoprofen) does not delay β-TCP bone graft healing | |
Torstrick et al. | Local strategies to prevent and treat osteoporosis | |
Galli et al. | Osteoconductive potential of mesoporous titania implant surfaces loaded with magnesium: an experimental study in the rabbit | |
BR0313954A (pt) | Composição de cerâmica biocompatìvel, dispositivo médico, método para fabricar uma composição de cerâmica biocompatìvel, implantes médico e ortopédico, material de enchimento dental ou implante dental, veìculo de droga para liberação de droga no corpo de um paciente, uso da composição de cerâmica biocompatìvel, método para gerar calor in vivo no corpo de um paciente para propósitos terapêuticos, e, método terapêutico | |
Saito et al. | Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder | |
BR112015013539A2 (pt) | composições de formação de cimento, cimentos monetita, implantes e métodos para a correção de defeitos de ossos | |
AR046282A1 (es) | Biomateriales compuestos para implantes oseos | |
Dewi et al. | Behavior of plaster of Paris‐calcium carbonate composite as bone substitute. A study in rats | |
WO2008079400A3 (en) | Surgical applications for bmp binding protein | |
AU2002218093A1 (en) | Connective tissue substitutes, method of preparation and uses thereof | |
Zwolak et al. | Local effect of zoledronic acid on new bone formation in posterolateral spinal fusion with demineralized bone matrix in a murine model | |
Parisi et al. | Aptamers recognizing fibronectin confer improved bioactivity to biomaterials and promote new bone formation in a periodontal defect in rats | |
Chaudhari et al. | Bone tissue response to BMP‐2 adsorbed on amorphous microporous silica implants | |
Zogakis et al. | Bisphosphonate-loaded bone cement: Background, clinical indications and future perspectives |